lisvy transdermal patch 60mcg 24h13mcg 24h - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

exelon patch 5 rivastigmine 4.6mg/24 hours transdermal drug delivery system sachet

novartis pharmaceuticals australia pty ltd - rivastigmine, quantity: 9 mg - drug delivery system, transdermal - excipient ingredients: acrylates copolymer; dimeticone 12500; dl-alpha-tocopherol; ethyl acetate; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane; methylated trimethylated silica - exelon / prometax is indicated for the treatment of patients with mild, moderate and severe dementia of the alzheimer's type.

Australia - English - Department of Health (Therapeutic Goods Administration)

androderm testosterone 24.3 mg per patch transdermal drug delivery system sachet

teva pharma australia pty ltd - testosterone, quantity: 24.3 mg - drug delivery system, transdermal - excipient ingredients: ethanol; sodium hydroxide; glyceryl monooleate; methyl laurate; carbomer copolymer (type b); glycerol; purified water; ethyl acetate; toluene; acrylates/va copolymer - indicated for testosterone replacement therapy for confirmed testosterone deficiency in males.

New Zealand - English - Medsafe (Medicines Safety Authority)

oxytrol

teva pharma (new zealand) limited - oxybutynin 36mg - transdermal patch - 3.9 mg/24h - active: oxybutynin 36mg excipient: duro-tak 87-2888 acrylic adhesive backing film. scotchpak 9739 release liner (grade 10393 s 3 cl pet 4400b/000) triacetin - the treatment of overactive bladder with symptoms of urinary frequency, urgency or incontinence or any combination of these symptoms.